Skip to main content
. Author manuscript; available in PMC: 2017 Aug 15.
Published in final edited form as: J Immunol. 2016 Jul 11;197(4):1118–1126. doi: 10.4049/jimmunol.1600549

Figure 1. Enrollment, colonization and infection status.

Figure 1

A. Schematic representation of enrollment among controls and SSTI patients. B. Distribution of the chief complaint by uninfected controls presenting to the ED. C. Enrolled individuals were swabbed at 3 body sites and the colonization status and genotype of the S. aureus strain when at least 1 site was positive were determined at the first visit to the ED for SSTI patients and uninfected controls (D0) as well as on D40 for SSTI patients. D. Patients presenting with SSTI on D0 had their skin lesion incised and drained when possible and the obtained material sent to the laboratory for genotyping. Patients whose samples grew S. aureus MRSA or MSSA in the clinical microbiology laboratory but that were not genotyped are labeled as untyped. Patients whose samples were not obtained or whose culture was negative are labeled as unknown.